Decheng Capital China Life Sciences Usd Fund Iii, L.p. - Net Worth and Insider Trading
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Net Worth
The estimated net worth of Decheng Capital China Life Sciences Usd Fund Iii, L.p. is at least $306 Million dollars as of 2024-09-20. Decheng Capital China Life Sciences Usd Fund Iii, L.p. is the 10% Owner of Alpine Immune Sciences Inc and owns about 4,708,288 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $306 Million. Details can be seen in Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Decheng Capital China Life Sciences Usd Fund Iii, L.p. has not made any transactions after 2021-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Decheng Capital China Life Sciences Usd Fund Iii, L.p. owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Cue Health Inc (HLTHQ) .
Insider Ownership Summary of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2021-09-17 | 10 percent owner |
| HLTHQ | Cue Health Inc | 2021-09-23 | 10 percent owner |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Latest Holdings Summary
Decheng Capital China Life Sciences Usd Fund Iii, L.p. currently owns a total of 1 stock. Decheng Capital China Life Sciences Usd Fund Iii, L.p. owns 4,708,288 shares of Alpine Immune Sciences Inc (ALPN) as of September 17, 2021, with a value of $306 Million.
Latest Holdings of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2021-09-17 | 4,708,288 | 64.97 | 305,897,471 |
Holding Weightings of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Decheng Capital China Life Sciences Usd Fund Iii, L.p. has made a total of 1 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 1,542,553 shares on September 17, 2021, which cost Decheng Capital China Life Sciences Usd Fund Iii, L.p. around $15 Million.
Insider Trading History of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
- 1
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Decheng Capital China Life Sciences Usd Fund Iii, L.p. is 36.2%. GuruFocus also compares Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Decheng Capital China Life Sciences Usd Fund Iii, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Decheng Capital China Life Sciences Usd Fund Iii, L.p.'s insider trading performs compared to the benchmark.
Performance of Decheng Capital China Life Sciences Usd Fund Iii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.8 | | | | | |
| Relative Return to S&P 500(%) | 12.93 | | | | | |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Ownership Network
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Owned Company Details
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Decheng Capital China Life Sciences Usd Fund Iii, L.p. is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Decheng Capital China Life Sciences Usd Fund Iii, L.p. made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Peter A. Thompson .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
Decheng Capital China Life Sciences Usd Fund Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Decheng Capital China Life Sciences Usd Fund Iii, L.p.. You might contact Decheng Capital China Life Sciences Usd Fund Iii, L.p. via mailing address: Ugland House, Po Box 309, Grand Cayman E9 Ky1-1104.
Discussions on Decheng Capital China Life Sciences Usd Fund Iii, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
